Taiyen Biotech Co., Ltd. (1737)
Market Closed
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
30. 25
+0.15
+0.4983%
NT$
6.39B Market Cap
28.92 P/E Ratio
2.52% Div Yield
253,784 Volume
1.36 Eps
NT$ 30.1
Previous Close Want to track 1737 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taiyen Biotech Co., Ltd. (1737) Statistics
Valuation metrics
Market Cap 6.39B
Enterprise value 4.66B
Trailing P/E (ttm) 15.38
Forward P/E -
PEG ratio 1.43
Price/Sales (ttm) 1.88
Price/Book (mrq) 0.9
Enterprise Value/Revenue 1.46
Enterprise Value/EBITDA 6.89
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 125.25K
Average volume (90 days) 275.44K
Price summary
52-Week low 29.3
52-Week high 32.5
Beta -
50-Day moving average 30.46
200-Day moving average 31.5
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.4
Trailing annual dividend yield 0.0467%
5-Year annual dividend yield -
Payout ratio 0.64
Dividend Date 18 Sep 2026
Ex-Dividend Date 24 Aug 2026
Last split factor 0:1
Last split Date 16 Dec 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 15.93
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.82
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 2.48%
Book value per share (mrq) 33.51
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
